BNET Industries
Last Fiscal Year Sales:$9.8M
- Public
- US
Dow Jones Description
TorreyPines Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel small molecule drugs for Alzheimer's Disease and chronic pain.
Number of Employees 13
Contact Information
11085 N Torrey Pines Rd Ste 300
LA Jolla, California 92037
1 858 623 5665
Peer Companies
NAICS Code Pharmaceutical Preparation Manufacturing: 325412
Recent Events
-
Raptor Pharmaceuticals Corp. and TorreyPines Complete Merger
-
Company, People, and Regulatory Briefs: Amgen and GSK Collaborate; WuXi Appoints VP of Pharmacology; More...
News & Analysis
Filter by
torreypines therapeutics inc. - All News and Analysis
Will TorreyPines Sale of Its Alzheimer Genetics Research Save the Company?
Seeking Alpha
- 2008-11-11
Eben Tessari submits: TorreyPines Therapeutics, Inc. TPTX Tuesday announced that it has agreed to sell its Alzheimer’s disease genetics research program to Eisai Co., Ltd. for an upfront cash payment. TorreyPines and Eisai have collaborated on the genetics program since 2002, with the most recent agreement between the parties concluding...
- 1
Industry Transcripts by Seeking Alpha
-
Peregrine Pharmaceuticals Inc. F2Q10 (Qtr End 31/10/09) Earnings Call Transcript
on Dec 10, 2009about PPHM
-
Avanir Pharmaceuticals F4Q09 (Qtr End 09/30/2009) Earnings Call Transcript
on Nov 24, 2009about AVNR
-
Palatin Technologies F1Q10 (Qtr End 9/30/09) Earnings Call Transcript
on Nov 16, 2009about PTN
-
Flamel Technologies SA Q3 2009 Earnings Call Transcript
on Nov 16, 2009about FLML
-
NexMed Inc. Q3 2009 Earnings Call Transcript
on Nov 10, 2009about NEXM
Glass Door
Pharma Industry Companies
| Company | Employer Rating |
| Johnson & Johnson |  |
| Merck | |
| Pfizer | |
| Novartis |  |
| Abbott Labs | |
IndustryTop Rated
- How NOT to Write a Biotech Press Release: Just Ask Epeius 5 votes
- Teva, In Turnabout, Sues to Protect Its Multiple Sclerosis Drug Copaxone 3 votes
- Fired Whistleblower Reps Make Similar Claim: Pfizer Said They Lacked "Integrity" 3 votes
- Why J&J's Stelara Launch Should Target Dermatologists First 3 votes
- BioCryst's Antiviral Drug Peramivir Aims to Keep Swine-Flu Body Count Low 3 votes
Presented by American Express